NUB Archive

The pathway to German hospitals for medical devices, digital health applications and drugs can be straight forward in Germany. However, in the meantime there are various pathways available including the famous “NUB” and the newly introduced Hospital Future Act as well as experimental coverage and innovation fund applications. Additionally, investment goods need to differentiate between hospital ownerships.
The presenters, both long-lasting members of the Inpatient committee at the German Health Economic Association, will discuss the various pathways and applicability as well as the correlation to the annual budget negotiations of hospitals and will show the various aspects to consider when planning a launch into the German hospital setting.

Existing guidelines support the importance of nutritional interventions for medical inpatients at malnutrition risk to alleviate the impact of malnutrition on outcomes. MArS in conjunction with the investigators of the EFFORT – a pragmatic, investigator-initiated, open-label, multicenter Swiss trial have developed and executed a probabilistic health economic analysis. Our evaluation demonstrates that in-hospital nutritional support for medical inpatients is a highly cost-effective intervention in Switzerland to reduce risks for ICU admissions and hospital-associated complications, while improving patient survival.

The full article is available on the website of the Journal of Clinical Nutrition

MArS has a strong background in health economics, the related data analytics, medical writing and communication with payers. We have developed various health economic analyses in the last years which lead to over 35 manuscripts in scientific journals and more than 150 presentations at conferences.

Access to German hospitals – pathways to follow

Secondary HE analysis on the EFFORT study published!